Srijanee Das

6PUBLICATIONS
24CO-AUTHORS
Medical devicesGene and molecular therapyNanomedicineMedical molecular engineering of nucleic acids and proteinsInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tail.

Mohammad Ullah Nayan, Brady Sillman, Srijanee Das

|Aug 01, 2025
A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression.

Samiksha S Raut, Srijanee Das, Grace Bybee

|Mar 04, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic Tail.

Benson Edagwa, Mohammad Ullah Nayan, Brady Sillman

|Jul 30, 2024
Development of an extended action fostemsavir lipid nanoparticle.

Farhana Islam, Srijanee Das, Md Ashaduzzaman

|Dec 23, 2022
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression.

Srijanee Das, Weimin Wang, Murali Ganesan

|Jun 23, 2021
The Immunopathobiology of SARS-CoV-2 Infection.

Milankumar Patel, Farah Shahjin, Jacob D Cohen

Pageof 1